Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
The patient, a 30-year-old female, was admitted to the hospital in December 2024 with a chief complaint of "abnormal urinalysis for more than a year." She had been diagnosed with polycystic ovary syndrome through previous examinations and had a history of induced abortions and miscarriages. Her marital and reproductive history, as well as her personal and family medical history, were unremarkable. Physical examination revealed no signs of edema in the eyelids or facial area, and there were no abnormal findings in the examination of the heart, lungs, and abdomen.
Urinalysis: Red blood cells: 61.0/μL , Glucose: 3+, Occult blood: 1+, Protein: 2+; Renal function and electrolytes: Serum uric acid: 541umol/L, total cholesterol: 6.42 mmol/L, serum triglycerides: 13.57mmol/L; Urine protein quantification: 3027.6mg/24h; Glycosylated hemoglobin: 7.7%; OGTT test abnormal; Visual and auditory examinations normal.
Pathological findings: Light microscopy: 9 glomeruli were observed , 2 glomeruli showed segmental sclerosis.A few glomeruli were enlarged .Mild segmental proliferation of mesangial cells and matrix.Tubular dilation and focal atrophy (atrophy area of ~5%).Occasional foam cell infiltration.Mild thickening of the arterial wall with segmental hyalinization.Immunofluorescence: α3 glomerular basement membrane and renal tubular basement membrane show segmental reduction in expression.Electron microscopy: Basement membranes: some areas are thinner (about 60%), with a thickness less than 250nm, while the thickest areas reach up to 350nm.Genetic test results: The c.4464G>C mutation in the COL4A4 gene is classified as a variant of uncertain significance.
Diagnosis :1. Alport syndrome 2. Obesity-related kidney disease 3. Metabolic syndrome Obesity Type 2 diabetes Mixed hyperlipidemia 4. Hyperuricemia 5. Fatty liver disease 6. Pulmonary Nodules 7. Polycystic Ovary Syndrome.Treatment methods 1. Weight reduction 2. Metformin, dapagliflozin, sacubitril/valsartan, atorvastatin calcium, febuxostat.
The clinical outcome is monitored with a 24-hour urinary protein quantification of 0.1g~0.4g, with a current BMI of 29kg/m², blood pressure of 120/80mmHg, fasting blood glucose of 5-6mmol/L.
